UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
Back to Urology at UCLA home It Begins With U

Urology at UCLA

Print
Email
Share

Testicular Cancer Doctors

IUO
Phone: (310) 794-7700

Appointment Request Form

Testicular Cancer Doctors, Los Angeles, CA

Affiliated: Find a Doctor | Overview | Symptoms | Treatment | Diagnosis

We offer personalized care that includes the latest testicular cancer treatments in surgery, chemotherapy and radiation therapy.

The Program is part of the Institute of Urologic Oncology in the UCLA Department of Urology and is affiliated with UCLA's Jonsson Comprehensive Cancer Center. We are committed to a team approach to caring for our patients with testicular cancer. This includes well-coordinated efforts from our urologists, medical oncologists, radiation oncologists, pathologists, radiologists, nurses, and office staff.

 
William Aronson, MD
William Aronson, MD
Chief of Urology at Olive View UCLA Medical Center and Chief of Urologic Oncology, Veterans Administration West Los Angeles. His clinical specialties are Prostate Cancer and General Urology. His clinical and laboratory research focuses on treatment of advanced prostate cancer and diet and lifestyle factors for chemoprevention and treatment.
 
Arie Belldegrun, MD, FACS
Arie Belldegrun, MD, FACS
Director of the Institute of Urologic Oncology (www.iuo.ucla.edu); Professor of Urology; Chief, Division of Urologic Oncology; Founder and Surgical Director, UCLA Kidney Cancer Program (www.kidneycancer.ucla.edu). Dr. Belldegrun also holds the Roy and Carol Doumani Chair in Urologic Oncology and serves as the Director of the Urologic Oncology Fellowship Program at UCLA. His surgical expertise encompasses all aspects of urologic oncology, including kidney cancer, prostate cancer, bladder cancer and testicular cancer. He has authored over 400 peer-reviewed publications, books, and book chapters in the area of localized and advanced kidney and prostate cancer. Dr. Belldegrun is a world-renown expert in complicated kidney cancer surgeries, and has unique expertise in a variety of surgical approaches to small kidney tumors including open, laparoscopic, and robotic partial nephrectomy and cryotherapy. He is also a recognized expert in minimally invasive and focal prostate cancer therapy, specifically cryo-surgical prostate cancer ablation, and has published extensively his UCLA experience with cryotherapy. Dr. Belldegrun's research lab at UCLA focuses on the development of personalized cancer immunotherapy and targeted cancer vaccines for the treatment of kidney cancer.
 
Karim Chamie, MD, MSHS
Karim Chamie, MD, MSHS
Assistant Professor-in-Residence of Urology. He attended Medical School at USC and completed Urological training at UC Davis. Dr. Chamie then completed a SUO certified fellowship in Urologic Oncology at UCLA. His primary research interests are health services research and clinical trials in bladder cancer. His clinical interests include all areas of urologic oncology, with a particular emphasis on bladder cancer and robotic surgery.
 
Jean B. DeKernion, MD
Jean B. DeKernion, MD
Professor Emeritus of Urology. Residency, Case Western Reserve in Cleveland, fellowship, National Cancer Institute. Certified by the American Board of Surgery and American Board of Urology. World leader in Urologic Oncology, co-authored the first textbook on the subject. Founder, Society of Urologic Oncology, member of the American Board of Urology, Chair, Department of Defense prostate cancer Research program. Kidney, bladder and prostate cancer are the areas in which he has made the most significant contributions.
 
Isla Garraway, MD
Isla Garraway, MD
Associate Professor of Urology at UCLA, Attending Urologist, Greater Los Angeles-VA Medical Center. Dr. Garraway’s primary clinical and research focus is on prostate cancer. She is a member of the Jonsson Comprehensive Cancer Center and heads a laboratory investigating prostate development and carcinogenesis.
 
Jim C. Hu, MD, MPH
Jim C. Hu, MD, MPH
Director and Henry Singleton Chair in Robotic and Minimally Invasive Surgery, Co-Director of the UCLA Center for Advanced Surgical and Interventional Technology and Director of the Urology Procedures Unit at UCLA. Dr. Hu is internationally renowned as a surgical innovator and for his comparative effectiveness research on robotic-assisted surgery to treat prostate, kidney and bladder cancer. He has performed over 2000 robotic-assisted procedures and was previously the Director of Robotic Surgery at Brigham and Women's Hospital-Harvard Medical School and Director of Prostate Cancer at the Dana Farber-Harvard Cancer Center before his recruitment to UCLA in 2012.
 
Mark S. Litwin, MD, MPH
Mark S. Litwin, MD, MPH
Chair, Department of Urology. Professor of Urology and Public Health. He trained at Harvard and specializes in testicular, bladder, prostate and kidney cancer. Dr. Litwin’s research focuses on improving quality of care and quality of life in urologic oncology. He leads Urologic Diseases in America (www.udaonline.net), the NIH’s largest effort at documenting the burden of urologic diseases on the American people. He also created and directs IMPACT, a state-funded program that provides free medical care statewide for low-income, uninsured men with prostate cancer (www.california-impact.org).
 
Leonard S. Marks, MD
Leonard S. Marks, MD
Professor of Urology, completed training at UCLA in 1978. Received an American Foundation for Urologic Diseases scholarship award and a prostate cancer Foundation research award. His current research interests involve prostate markers, imaging, and minimally-invasive treatments.
 
Allan Pantuck, MD, MS, FACS
Allan Pantuck, MD, MS, FACS
Professor of Urology, Dr. Pantuck specializes in urologic cancers and has a long standing interest in kidney, prostate, bladder cancers, developing new treatment strategies through basic and clinical research and in the study of nutritional approaches to their prevention and treatment.
 
Jacob Rajfer, MD
Jacob Rajfer, MD
Professor of Urology at UCLA and Chief of Urology, Harbor-UCLA Medical Center. Head of the male infertility and male sexual dysfunction clinic, Urology. Dr. Rajfer was one of the discoverers of the mechanism by which a man’s erection occurs which led to the discovery of drugs like Viagra. Dr. Rajfer also treats men with benign and malignant prostate disorders.
 
Robert E. Reiter, MD
Robert E. Reiter, MD
Professor, Urology, Molecular Biology, Director of the Prostate Cancer Program, Director of Urologic Research, Co-Director of the Genitourinary Oncology Program in UCLA's Jonsson Cancer Center. Attended Stanford Medical School, completed urologic training at Stanford and Baylor College of Medicine, completed additional fellowship training in urological cancer at the National Cancer Institute. His clinical interests include all areas of urologic oncology, with an emphasis on prostate cancer. He specializes in robotically-assisted prostatectomy and cystectomy, as well as open surgery, with robotic experience dating back to 2004, for bladder, prostate, and renal malignancies. Dr. Reiter is involved in all aspects of urologic oncology, with an emphasis on prostate cancer, and brings extensive experience in robotic surgery and the applications of translational research and the latest in MRI and molecular imaging to the management of men with this disease.
 
Matthew Rettig, MD
Matthew Rettig, MD
Matthew Rettig, M.D., is a Professor in the Department of Medicine, Division of Hematology-Oncology, and the Department of Urology, and is the Medical Director of the Prostate Cancer Program of the Institute of Urologic Oncology at UCLA. Dr. Rettig received his medical degree from Duke University and internal medicine residency at the University of Washington, before going on to a hematology-oncology fellowship at UCLA. Dr. Rettig’s focus is on management of genitourinary malignancies, with a clinical emphasis on advanced prostate cancer and research emphasis on identifying biochemical targets for therapeutic translation in castration-resistant prostate cancer and clear cell renal cell carcinoma. Dr. Rettig also serves as the director of the clinical trials program in prostate cancer at UCLA.
 
Christopher Saigal, MD, MPH
Christopher Saigal, MD, MPH
Professor and Vice Chair, Urology. Clinical practice, UCLA Westwood Campus. He is also on the staff of the West Los Angeles Veterans Affairs Medical Center. Dr. Saigal has had a longstanding clinical interest in urologic cancers and the surgical treatment of benign prostatic hyperplasia. His research is focused on patient-centered decision support and quality of care for urologic conditions.
 
Robert B. Smith, MD
Robert B. Smith, MD
Professor, Urology. Faculty member, completed UCLA residency, 1969. Assistant Professor of Urology, Chief of the Renal Transplant service. Associated Professor of Urology / Professor of Urology. Served in the Air Force, Lieutenant Colonel, Chief of Urology, Lackland Air Force Base. Vice-Chairman, Urology, Chief of Staff, UCLA Medical Center. Director, Urology residency training. His clinical interests are in the treatment of urologic malignancies, and in reconstructive urologic cases.
 
UCLA Rated One of the Top Hospitals in the Nation